Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients

Keyphrases

• Immune Response 100%
• Cancer Patients 100%
• In Cancer 100%
• Neoantigen 100%
• T Cell Response 50%
• Malignant Disease 33%
• Tumor Rejection 33%
• Anti-CTLA-4 33%
• Anti-PD-1 Antibody 33%
• Therapeutic Use 16%
• Interdependence 16%
• Post-translational Modification 16%
• T Cells 16%
• Immune Regulation 16%
• Cancer Immunotherapy 16%
• Tumor Cells 16%
• Non-self 16%
• Tumor Microenvironment 16%
• Viral Proteins 16%
• Target Identification 16%
• Antigen Processing 16%
• T-cell Mediated 16%
• Immunodominance 16%
• Mutant Protein 16%
• Peptide Ligand 16%
• Diverse Sources 16%
• Altered Peptide Ligands 16%
• Pharmacodynamics 16%
• Immune Checkpoint Modulators 16%
• Advanced Malignancies 16%
• Immunotherapeutic Strategy 16%

Immunology and Microbiology

• Neoantigen 100%
• Immune Response 100%
• T Cell 83%
• Tumor Rejection 33%
• Peptides 33%
• Programmed Death-Ligand 1 16%
• Immunodominance 16%
• Tumor Cell 16%
• Protein Processing 16%
• Pharmacodynamics 16%
• Cancer Immunotherapy 16%
• Antigen Presentation 16%